Skip Navigation
Search Menu
Find an Expert

 


Harry Quon, M.D.

Photo of Dr. Harry Quon, M.D.

Co-Director, Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic

Associate Professor of Radiation Oncology and Molecular Radiation Sciences

Male

Expertise: Head and Neck Cancers, Radiation Oncology

Locations

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Appointment Phone: 410-502-8000

401 N. Broadway
Baltimore, MD 21231 map

Background

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. 

He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic.

Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center.

 

...read more

Titles

  • Co-Director, Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic
  • Associate Professor of Radiation Oncology and Molecular Radiation Sciences
  • Associate Professor of Oncology
  • Associate Professor of Otolaryngology - Head and Neck Surgery

Education

Degrees

  • MD, University of Toronto - Institute of Medical Science (1993)

Residencies

  • Princess Margaret Hospital / Radiation Oncology (1998)

Fellowships

  • Princess Margaret Hospital / Radiation Oncology (1999)
  • Beth Israel Medical Center Department of Radiation Oncology / Radiation Oncology (2000)

Board Certifications

  • American Board of Radiology / Radiation Oncology (1999, 2010)

Research & Publications

Research Summary

Dr. Quon’s research focuses on reducing treatment toxicity. He is leading research into different strategies that are de-intensifying therapy in oropharynx cancers that are associated with the human papillomavirus (HPV).

Clinical Trials

A Phase II Study of Treatment De-Intensification in Favorable Squamous Cell Carcinoma of the Oropharynx

Is this you? Edit Profile